DuPont de Nemours (DD) Q4 2025

Q1 2026 Q4 2025 Q3 2025 Q2 2025

Earnings

DuPont de Nemours delivered a clean beat to close out fiscal 2025, posting Q4 adjusted EPS of $0.46 against a consensus estimate of $0.43, a 6.60% beat, while revenue of $1.69 billion edged just ahead of the $1.69 billion Wall Street expected. The he… Read more DuPont de Nemours delivered a clean beat to close out fiscal 2025, posting Q4 adjusted EPS of $0.46 against a consensus estimate of $0.43, a 6.60% beat, while revenue of $1.69 billion edged just ahead of the $1.69 billion Wall Street expected. The headline revenue figure reflects a steep 45.3% year-over-year decline, though that drop is largely a structural artifact of the November 2025 separation of its Electronics business into newly independent Qnity, along with the pending aramids divestiture. On a continuing-operations basis, the underlying business held essentially flat, with adjusted EPS climbing 18% from $0.39 in the year-ago period, driven by higher segment earnings and lower interest expense. Healthcare and Water Technologies, the company's newly constituted segment, contributed $821 million in net sales with 3% organic growth, anchoring the beat alongside cost productivity gains in Diversified Industrials. With analysts maintaining a moderate buy consensus and a $2 billion buyback authorization in place, DuPont's 2026 guidance calling for net sales of $7.08 to $7.13 billion and adjusted EPS of $2.25 to $2.30 frames the post-separation business as the primary growth story going forward.